Phase I study of in vivo lenograstim (rHuG-CSF) for stem cell collection demonstrates improved neutrophil recovery after autologous bone marrow transplantation.

Source:http://linkedlifedata.com/resource/pubmed/id/7519936

Download in:

View as

General Info

PMID
7519936